Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03317496
Title Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer
Indications

lung non-small cell carcinoma

transitional cell carcinoma

urethra transitional cell carcinoma

Advanced Solid Tumor

ureter transitional cell carcinoma

renal pelvis transitional cell carcinoma

Therapies

Avelumab + Cisplatin + Gemcitabine

Avelumab + Carboplatin + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST